Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plant Sterol Supplement for LDL-C Lowering in South Asians
NCT04030247Phase 4Completed
- Sponsor
- Stanford University
- Start
- Jan 2020
- Primary completion
- Mar 2021
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial, sponsored by Stanford University. Primary endpoint: Low Density Lipoprotein Cholesterol at 3 months. Started Jan 2020; status: completed.
Beyond the preview
Go deeper on NCT04030247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04030247.